| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013698A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013668A1 Pharmaceutical composition for treatment of ischemic events |
| 02/03/2011 | WO2011013646A1 Pharmaceutical product for prevention and treatment of amyotrophic lateral sclerosis |
| 02/03/2011 | WO2011013612A1 Peptidic compound and use of same |
| 02/03/2011 | WO2011013358A1 Anti-tumor agent |
| 02/03/2011 | WO2011013019A1 Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients |
| 02/03/2011 | WO2011012774A1 Novel form of osteogenic protein administration |
| 02/03/2011 | WO2011012718A1 Prodrugs comprising an insulin linker conjugate |
| 02/03/2011 | WO2011012585A1 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity |
| 02/03/2011 | WO2011012306A2 Use of emps for antagonising epo-stimulatory effects on epo-responsive tumors while maintaining erythropoiesis |
| 02/03/2011 | WO2011012080A1 Derivative of glp-1 analogue or its pharmaceutical salts and their use |
| 02/03/2011 | WO2011011976A1 Homing peptide for tumor vasculature |
| 02/03/2011 | WO2011011973A1 Fusion protein of anti-cd20 antibody fab fragment and lidamycin, preparation method and use thereof |
| 02/03/2011 | WO2011011927A1 Use of rnf13 protein and encoding gene thereof in the preparation of medicaments for preventing and/or treating mental cognitive disorders |
| 02/03/2011 | WO2011011847A2 Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases |
| 02/03/2011 | WO2011011843A1 Chemical method for sexual sterilisation and libido suppression in male mammals |
| 02/03/2011 | WO2011011808A1 A cosmetic composition comprising sodium chloride in combination with one or more of protein, collagen, gelatin or amino acid |
| 02/03/2011 | WO2010144344A3 Melanocortin receptor-specific peptides |
| 02/03/2011 | WO2010144341A3 Lactam-bridged melanocortin receptor-specific peptides |
| 02/03/2011 | WO2010141760A3 Antimicrobial peptides |
| 02/03/2011 | WO2010141097A8 Pegylated human apoa-1 and process for production thereof |
| 02/03/2011 | WO2010133306A8 Process for the preparation of ibodutant (men15596) and related intermediates |
| 02/03/2011 | WO2010129457A9 Vaccines against tularemia |
| 02/03/2011 | WO2010129276A3 PYRO-GLUTAMATE Aβ TARGETING AGENTS |
| 02/03/2011 | WO2010129267A3 Anti-trypanosomal peptides and uses thereof |
| 02/03/2011 | WO2010129233A9 Methods of treating bacterial infections using oritavancin |
| 02/03/2011 | WO2010128016A3 Par2 agonists for use in the treatment or prevention of influenza virus type a infections |
| 02/03/2011 | WO2010106187A3 Inhibitors of cathepsin s for prevention or treatment of obesity-associated disorders |
| 02/03/2011 | WO2010105188A9 Methods and systems for hemostasis using cryotherapy |
| 02/03/2011 | WO2010102281A3 Inhibitors of anaphase promoting complex activity |
| 02/03/2011 | WO2010091327A3 Method and compositions for treating skin |
| 02/03/2011 | WO2010065961A3 Compositions and methods relating to mir-31 |
| 02/03/2011 | WO2009158412A8 Sustained delivery of exenatide and other polypeptides |
| 02/03/2011 | WO2007035872A3 Tdf-related compounds and analogs thereof |
| 02/03/2011 | US20110030108 Mammalian-type glycosylation in plants |
| 02/03/2011 | US20110030077 METHODS OF MODULATING THE ORGANIC SOLUTE AND STEROID TRANSPORTER (OSTalpha-OSTbeta) ACTIVITY AND TREATING ASSOCIATED CONDITIONS |
| 02/03/2011 | US20110029030 Methods and Compositions for Treating a Disease Condition in a Subject |
| 02/03/2011 | US20110028698 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 02/03/2011 | US20110028691 Recombinant toxin fragments |
| 02/03/2011 | US20110028690 Novel bag proteins and nucleic acid molecules encoding them |
| 02/03/2011 | US20110028686 Protein binding miniature proteins |
| 02/03/2011 | US20110028409 Detection of anti-ribosomal p protein antibodies by means of synthetic peptides |
| 02/03/2011 | US20110028408 diagnostic molecule and therapeutic target |
| 02/03/2011 | US20110028407 Enhancement of innate resistance to infection |
| 02/03/2011 | US20110028406 Pharmaceutical Compositions Comprising A Cyclosporin, A Hydrophilic Surfactant and a Lipophilic Surfactant |
| 02/03/2011 | US20110028405 Sulfamides as zap-70 inhibitors |
| 02/03/2011 | US20110028404 Composition Comprising Vegetable Peptone for Promoting Stem Cell Proliferation |
| 02/03/2011 | US20110028403 HSP70-Based Treatment for Autoimmune Diseases and Cancer |
| 02/03/2011 | US20110028402 Substance p-saporin (sp-sap) conjugates and methods of use |
| 02/03/2011 | US20110028401 Cripto blocking molecules and therapeutic uses thereof |
| 02/03/2011 | US20110028400 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
| 02/03/2011 | US20110028399 Citrullinated cytokines |
| 02/03/2011 | US20110028398 Methods for treating and limiting fibrotic disorders and keloids |
| 02/03/2011 | US20110028397 Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders |
| 02/03/2011 | US20110028396 Medical composition |
| 02/03/2011 | US20110028395 Peptide modulators of angiogenesis and use thereof |
| 02/03/2011 | US20110028394 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | US20110028393 Flowable paste and putty bone void filler |
| 02/03/2011 | US20110028392 Methods for use of branched amino acids |
| 02/03/2011 | US20110028391 Use of GLP-1 Peptides |
| 02/03/2011 | US20110028390 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 02/03/2011 | US20110028389 Use of infant formula with reduced protein content |
| 02/03/2011 | US20110028388 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110028386 Antimicrobial Peptides |
| 02/03/2011 | US20110028385 Combination of Immunomodulator and Anti-Pathogenic Agent |
| 02/03/2011 | US20110028384 Rap variants for drug delivery |
| 02/03/2011 | US20110028383 Activated Forms Of Notch And Methods Based Thereon |
| 02/03/2011 | US20110028382 Treatment of oral pharyngeal dysphagia |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027867 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs |
| 02/03/2011 | US20110027860 Gene encoding chondroitinase abc and uses therefor |
| 02/03/2011 | US20110027807 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/03/2011 | US20110027805 Acpl-related assays |
| 02/03/2011 | US20110027391 Liquid nucleotides/nucleosides-containing product |
| 02/03/2011 | US20110027389 Low Viscosity Liquid Polymeric Delivery System |
| 02/03/2011 | US20110027382 Solubilized benzoyl peroxyde acne |
| 02/03/2011 | US20110027378 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/03/2011 | US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds |
| 02/03/2011 | US20110027366 Skin equivalent culture |
| 02/03/2011 | US20110027364 Bioactive and resorbable soybean-based biomaterials |
| 02/03/2011 | US20110027363 Nouvelle forme d'administration de proteines osteogeniques |
| 02/03/2011 | US20110027346 Lyase Enzymes, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 02/03/2011 | US20110027341 Device for in situ production and topical administration of allicin |
| 02/03/2011 | US20110027339 Porous implants and stents as controlled release drug delivery carriers |
| 02/03/2011 | US20110027337 Protease inhibitor |
| 02/03/2011 | US20110027332 Pliable medical device and method of use |
| 02/03/2011 | US20110027321 Chlamydia Vaccine Comprising HtrA Polypeptides |
| 02/03/2011 | US20110027315 Protein cages and their uses |
| 02/03/2011 | US20110027300 Identification of a novel cysteine-rich cell penetrating peptide |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027293 Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking |
| 02/03/2011 | US20110027285 Methods and agents modulating upa/upar activity |
| 02/03/2011 | US20110027283 Methods for diagnosing and treating cancers |
| 02/03/2011 | US20110027282 Interferon antagonists, antibodies thereto and associated methods of use |
| 02/03/2011 | US20110027279 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 02/03/2011 | US20110027278 Regulatory t cell mediator proteins and uses thereof |
| 02/03/2011 | US20110027277 Predictive marker for topoisomerase i inhibitors |
| 02/03/2011 | US20110027269 14-3-3 Antagonists for the Prevention and Treatment of Arthritis |